Directorate Change

8 September 2017
 

Syncona Limited
Legal Entity Identifier – 213800X8MBI5VQITLW60

Directorate Change

The Company announces the resignation of Peter Hames as a non-executive director of the Company, effective as of the completion of the Company’s Annual General Meeting today, 8 September 2017.  Mr. Hames has been a Board member since the Company listed in 2012, and the Company wishes to thank him for his invaluable contribution.
 

[ENDS]

Enquiries

Northern Trust International Fund Administration Services (Guernsey) Limited
Company Secretary
Tel:       01481 745001

Copies of this announcement and other corporate information can be found on the company website at:www.synconaltd.com 

About Syncona:

Syncona is a leading FTSE250 healthcare company focused on investing in and building global leaders in life science. Our vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders. Our current investment portfolio consists of seven high quality companies in life science and a leading range of fund investments.

We seek to partner with the best, brightest and most ambitious minds in science to build globally competitive businesses. We are established leaders in gene therapy, cell therapy and advanced diagnostics, and focus on delivering dramatic efficacy for patients in areas of high unmet need.

Our market leading funds portfolio seeks to generate superior returns by investing in long only and alternative investment funds. This represents a productively deployed evergreen funding base which enables us to take a long term approach to investing in life sciences as we target the best new opportunities and support our existing portfolio companies to grow and succeed.

Syncona is aligned with two of the premium charitable funders in UK science, the Wellcome Trust, original founder of Syncona, and Cancer Research UK, both of which are significant shareholders in our business.  We make a donation of 0.3% of Net Asset Value to a range of charities each year.

UK 100

Latest directors dealings